Sigma Labs Announces Third Quarter Financial Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Sigma Labs Announces Third Quarter Financial Results

SANTA FE, N.M., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Sigma Labs, Inc. (OTCQB:SGLB) (“Sigma Labs” or the “Company”), a provider of quality assurance software under the PrintRite3D® brand, today announced financial results for the three months ended September 30, 2016.

Recent Highlights

  • Completed a private placement of convertible notes and warrants that netted gross proceeds, before expenses, of $900,000 to Sigma Labs. Such funds will be used to support the Company’s working capital requirements and growth initiatives going forward
  • Entered into an agreement with Siemens Industrial Turbomachinery of Finspång, Sweden, for Sigma Labs’ PrintRite3D® INSPECT® to be installed on a metal printer for evaluation and testing purposes, which could lead to further orders in the future
  • Launched PrintRite3D® INSPECT™ v1.3.2, the next-generation of Sigma Labs’ In-Process Quality Assurance™ (IPQA®) software, which includes the addition of alloy-specific temperature correction algorithms, improved reporting, and enhanced graphics both layer-by-layer and part-by-part
  • Announced the receipt of a contract from Honeywell Aerospace under the “America Makes” project with GE Aviation, funded by the National Additive Manufacturing Innovation Institute. Sigma Labs and Honeywell will further demonstrate the benefits of IPQA® using Sigma Labs’ PrintRite3D® software
  • Presented at the American Welding Society’s Lasers Conference, August 29-30, and the Smartindustry 2016 Exhibition, September 26-28, both showcasing the Company’s PrintRite3D® software solutions

“Sigma Labs continued to focus on long term growth this quarter – winning new contracts and positioning the Company for faster expansion going forward,” said Mark Cola, President & CEO of Sigma Labs. “We are aggressively pursuing new business development opportunities and are encouraged by the high level of interest our software solutions receive in the industry – resulting in the potential for many new customer relationships, such as with Siemens. At the same time, we launched INSPECT™ 1.3.2 this quarter and are about to launch version 2.0 at the Formnext show in Frankfurt later this week. We also recently completed a private placement that brought in funds to fuel future R&D and sales. All in all, we believe the Company is in good shape to achieve higher top line growth as we turn the corner on fiscal 2017.”

2016 Third Quarter Financial Results Revenue for the three months ended September 30, 2016 was approximately $0.2 million versus approximately $0.3 million for the same period in 2015. The Company reported a net loss for the third quarter of approximately $0.7 million, or $(0.11) per diluted share, versus a loss of approximately $0.6 million, or $(0.09) per diluted share, for the third quarter of 2015.

Investor Conference Call The Company will host a conference call to discuss its 2016 third quarter financial results today, November 14, 2016, at 11:00 a.m. Eastern Time. To participate in the call, please dial toll free 1-844-802-2441, or 1-412-317-5134, approximately five minutes before the conference call time stated above. A live webcast of the call can also be accessed on the Sigma Labs website at www.sigmalabsinc.com . A recording will be available on the Company's website upon completion of the call.

About Sigma Labs, Inc. Sigma Labs, Inc. develops and engineers advanced, in-process, non-destructive quality inspection systems for commercial firms worldwide seeking productive solutions for metal-based additive manufacturing or 3D printing, and other advanced manufacturing technologies. For more information please visit us at www.sigmalabsinc.com . 

Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 .  Forward-looking statements often contain words such as "expects," "anticipates," "intends," "believes" or "will." Our forward-looking statements are subject to a number of risks, uncertainties and assumptions that could adversely affect us, including the risks set forth in our annual report on Form 10-K. The forward-looking statements in this press release are made only as of the date of this press release. We undertake no obligation to update our forward-looking statements, whether as a result of new information, future events or otherwise.

Sigma Labs, Inc.  
Condensed Statements of Operations  
(Unaudited)  
           
  Three Months Ended Nine Months Ended  
  September 30, 2016 September 30, 2015 September 30, 2016 September 30, 2015  
           
INCOME          
  Services $   189,951   $   266,566   $   642,230   $   648,515    
  Total Revenue     189,951       266,566       642,230       648,515    
           
COST OF SERVICE REVENUE     69,259       25,250       207,744       138,379    
           
  GROSS PROFIT     120,693       241,316       434,486       510,136    
           
EXPENSES          
  Other General and Administration     437,873       293,187       1,345,576       886,965    
  Payroll Expense     259,011       191,399       727,494       338,533    
  Stock-Based Compensation     105,630       221,500       236,554       478,500    
  Research and Development     37,532       122,517       88,504       206,545    
  Total Expenses     840,046       828,603       2,398,128       1,910,543    
           
OTHER INCOME (EXPENSE)          
  Interest Income     35       265       288       1,137    
  Other Income     -        -        31,626       -     
Venture     (3 )     (108 )     (105 )     (108 )  
  Total Other Income (Expense)     32       157       31,809       1,029    
           
LOSS BEFORE INCOME TAXES     (719,320 )     (587,130 )     (1,931,833 )     (1,399,378 )  
           
Provision for income Taxes     -         -         -         -      
           
Net Loss $     (719,320 ) $     (587,130 ) $     (1,931,833 ) $     (1,399,378 )  
           
Loss per Common Share - Basic and Diluted $     (0.11 ) $     (0.09 ) $     (0.31 ) $     (0.22 )  
           
Weighted Average Number of Shares          
  Outstanding - Basic and Diluted   6,267,577     6,259,349     6,267,577     6,243,642    
           

 

Sigma Labs, Inc.  
Unaudited Condensed Balance Sheets  
       
       
  September 30, 2016 December 31, 2015  
       
ASSETS      
  Current Assets      
  Cash $   137,702   $   1,539,809    
  Accounts Receivable, net     119,599       280,222    
  Inventory     84,659       20,129    
  Prepaid Assets     34,097       38,687    
  Total Current Assets     376,057       1,878,847    
       
       
  Other Assets      
  Property and Equipment, net     609,782       714,754    
  Intangible Assets, net     222,674       167,644    
  Investment in Joint Venture     500       9,222    
  Prepaid Stock Compensation       208,848       418,547    
  Total Other Assets     1,041,804       1,310,167    
       
TOTAL ASSETS $     1,417,861   $     3,189,014    
       
LIABILITIES AND STOCKHOLDERS' EQUITY        
  Current Liabilities      
  Accounts Payable $   143,217   $   38,393    
  Accrued Expenses     96,322       71,523    
  Total Current Liabilities     239,539       109,916    
       
TOTAL LIABILITIES     239,539       109,916    
       
  Stockholders' Equity        
  Preferred Stock, $0.001 par; 10,000,000 shares authorized;    
  None issued and outstanding     -        -     
  Common Stock, $0.001 par; 15,000,000 shares authorized;    
  6,267,577 and 6,239,073 issued and outstanding at      
  September 30, 2016 and 2015, respectively     6,268       6,239    
  Additional Paid-In Capital     10,668,007       10,636,979    
  Accumulated Deficit     (9,495,953 )     (7,564,120 )  
  Total Stockholders' Equity       1,178,322       3,079,098    
       
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY   $     1,417,861   $     3,189,014    
       

Investor Relations Contact: Chris Witty cwitty@darrowir.com; 646-438-9385

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 28

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 25

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 64

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 192

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 31

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 216

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 328

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 195

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Mercari and Suruga-ya Forge U.S. Venture for Culture

Updated Category News Views 13

Japanese Pop Culture Gears Up for US Market Surge Alright, folks, what we’ve got here is another bold move in the cross-border e-commerce game. Mercari and Suruga-ya are teaming up to establish a joint venture over in the U.S. The goal? To further capitalize on the growing appetite for Japanese entertainment and hobby goods among us all stateside. Now, it’s no secret...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 16

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading

Top 5 Most Recently Viewed Articles

GM Partners with Barclays to Enhance Credit Card Offerings

Updated Category News Views 71

General Motors and Barclays Sign a Strategic Partnership General Motors (NYSE: GM) and Barclays have recently announced a significant long-term partnership that focuses on credit card services. This strategic agreement reflects both companies' commitment to enhancing customer experience and providing innovative financial solutions. Benefits of the New Credit Card...

Continue Reading
Enbridge Inc. Declares 3% Increase in Quarterly Dividend

Updated Category News Views 126

Enbridge Inc. Increases Quarterly Dividend by 3% Enbridge Inc. (TSX: ENB) has made a significant announcement regarding its quarterly dividend. The company declared a quarterly dividend of $0.9425 per common share, signaling a 3% increase from previous rates. This notable hike reflects Enbridge's commitment to shareholder value and marks the thirtieth consecutive year of...

Continue Reading
Jefferies Advises Caution on Biotech-Related CRO Investments

Updated Category News Views 545

CROs Confront Challenges as Biotech Market Slows In a recent analysis, Jefferies is advising investors to rethink their investments in contract research organizations (CROs), particularly those focused on biotech and early-stage research. This caution comes as the demand in the biotech sector has noticeably declined. Financial Struggles Affects Companies Jefferies has...

Continue Reading
Remarkable Cost Savings with QUELIMMUNE for Pediatric AKI

Updated Category News Views 137

Significant Economic Impact of QUELIMMUNE Therapy SeaStar Medical Holding Corporation (Nasdaq: ICU), a pioneering healthcare company, has recently published a health economic analysis that underscores the substantial financial benefits of its QUELIMMUNE therapy for pediatric patients suffering from Acute Kidney Injury (AKI). The analysis highlights an estimated average...

Continue Reading
SKF Invites Fans to Revitalize Tattoos with Brand Update

Updated Category News Views 228

SKF Invites Fans to Revitalize Tattoos with Brand Update SKF has taken an impactful step to modernize its brand identity, showcasing a fresh and dynamic look aimed at connecting with its audience more effectively. This update marks the company's first significant change to its logo since its inception in 1908, highlighting the dedication to innovation while respecting its...

Continue Reading